Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q1 2016 · 10-Q
Revenue—
Net Income-$13.54M-$13.54MN/M vs Q1 2015 EPS Diluted-$0.49-$0.49N/M vs Q1 2015 Operating Cash Flow-$13,260,000N/M Free Cash Flowderived-$13,619,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 2, 2016 · 32 d after period end